Chlamydial urethritis in heterosexual men attending a genitourinary medicine clinic: prevalence, symptoms, condom usage and partner change [see comments]

Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Chlamydial urethritis in heterosexual men attending a genitourinary medicine clinic: prevalence, symptoms, condom usage and partner change [see comments]

Int J STD AIDS. 1995 Jan-Feb;6(1):27-30. Unique Identifier : AIDSLINE MED/95244660
Zelin JM; Robinson AJ; Ridgway GL; Allason-Jones E; Williams P; Department of Genitourinary Medicine, University College London; Hospitals, UK.

Abstract: A prospective study of 356 consecutive heterosexual male patients attending the Department of Genitourinary Medicine at University College Hospital was carried out to determine the prevalence of Chlamydia trachomatis. Patients were asked about their symptoms, use of condoms and change of sexual partner. The prevalence of non-gonococcal urethritis (NGU--chlamydia positive and negative urethritis) was 37% (131 of 356). C. trachomatis was shown to be the causative organism in 24% (31 of 131) of patients with NGU. The prevalence of other STDs in men with C. trachomatis and with non-chlamydial urethritis was 15% and 10% respectively. Men with C. trachomatis were significantly more likely than men with non-chlamydial urethritis to be asymptomatic (56% vs 35%). The prevalence of C. trachomatis was highest in men who had changed partner in the previous 3 months (20 of 32 men). A third of men never used condoms in the first 3 months of a new relationship and over half failed to use them after 3 months. There was no evidence that the reported use of condoms reduced the rate of infection with C. trachomatis.

Keywords: Adolescence Adult Aged Chlamydia Infections/*EPIDEMIOLOGY Chlamydia trachomatis/*ISOLATION & PURIF Condoms Human London Male Middle Age Prevalence Prospective Studies Sex Behavior Sexually Transmitted Diseases/*EPIDEMIOLOGY/PREVENTION & CONTROL Urethritis/EPIDEMIOLOGY/*MICROBIOLOGY JOURNAL ARTICLE
Comment in: Int J STD AIDS 1995 Jul-Aug;6(4):298; discussion 299
950830
M9580980

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .